• MUTYH Gene Mutation Analysis (Y165C and G382D) for MUTYH associated polyposis (MAP)
  • CD4/CD8 Lymphocyte Ratio
  • Beta-2 Microglobulin, Serum
  • Antithrombin Activity
  • Occult Blood, Fecal
  • Epidermophyton floccosum IgE
  • Human Immunodeficiency Virus 1 (HIV-1) RNA, Qualitative or Quantitative
  • Cytomegalovirus (CMV) CD8 T-Cell Immune Competence, Quantitative Assessment by Flow Cytometry
  • Culture, Synovial Fluid
  • Parvovirus B19 Antibody, IgG
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Enhancer of zeste homolog 2 (EZH2) Gene Mutation Analysis
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

Enhancer of zeste homolog 2 (EZH2) Gene Mutation Analysis
Medical Test

Additional Testing
Access to Enhancer of zeste homolog 2 (EZH2) Gene Mutation Analysis is restricted.